(Q48259600)

10 February 2018

title

Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed? (English)

1 reference

10 February 2018

main subject

Alzheimer's disease

0 references

author name string

Giulio Maria Pasinetti

series ordinal

1

1 reference

10 February 2018

Patrick Nicholas Pompl

series ordinal

2

1 reference

10 February 2018

publication date

1 November 2002

1 reference

10 February 2018

published in

Lancet Neurology

1 reference

10 February 2018

volume

1

1 reference

10 February 2018

issue

7

1 reference

10 February 2018

page(s)

403-404

1 reference

10 February 2018

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900214-4

7 January 2021

10.1016/S1474-4422(02)00214-4

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018